Company Name
Yiling Pharmaceutical Ltd.
Year of Establishment
2014
Annual Turnover(USD)
500,000 to 99,999,999
Company Introduction
Yiling Pharma established an international pharmaceutical platform in Beijing and Shijiazhuang with annual capacity of 6.4 billion tablets (capsules). Facilities was designed by world-class design firm with the GMP standard of US FDA and EU, and have been certified by US FDA, MHRA, China NMPA, TGA, Health Canada and Medsafe for many times. Yiling Pharma is one of the few companies which both certified by USFDA and MHRA.
Main Business and Advantages
CMO service: from submission to commercial batch for API and FDF
CSO service: for China market including Rx and OTC
Product supply: own-label product (CN and US ANDA products) for worldwide
Regulatory support: for CMO worldwide and CSO for CN
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.yiling.cn
Other Competitive Advantages
Strong CMO Capability
Various Technology, Dosage Forms and Flexible Batch Size
Multiple technology: granulation (wet, dry), pelleting tableting, contained processing
Multiple dosage form: general and ER tablets/capsules, injection (vial, ampoule and lyophilized)
Flexible batch size: linear scale-up capabilities from 1-1600kg
Abundant CMO Experience
10+ Innovative drugs with different clients, and several have been launched
15+ Generic drugs wit different clients, and some varieties are pending approval
30+ Approved site transfer for partners in China, UK, Canada, New Zealand and other countries and commercial production is opening
Excellent Project Operation
Experienced staff for expeditious technology transfer
Fully automated manufacturing
Consummate record system is still in continuous refinement phase
Excellent on-time delivery track record